Rachel Brough
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Cancer therapeutics and mechanisms
Papers in
-
- DNA Repair Mechanisms 15
- CRISPR and Genetic Engineering 13
- Chromatin Remodeling and Cancer 4
- Genomics and Chromatin Dynamics 3
- Oncology 23
- PARP inhibition in cancer therapy 14
- Cancer-related Molecular Pathways 6
- Co-authors
- Christopher J. Lord (33 shared papers)Alan Ashworth (20 shared papers)Rachael Natrajan (9 shared papers)Jorge S. Reis‐Filho (4 shared papers)Radost Vatcheva (2 shared papers)Stacey L. Edwards (1 shared paper)Douglas A. Levine (1 shared paper)Jeff Boyd (1 shared paper)
- Journals
- Oncogene (4 papers)Cancer Research (3 papers)Cell Reports (2 papers)PLoS ONE (2 papers)The EMBO Journal (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Rachel Brough
38 papers receiving 3.1k citations
Rachel Brough's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 2.0k
- Molecular Biology 2.2k
- Cancer Research 389
- Reproductive Medicine 217
- Genetics 415
Countries citing papers authored by Rachel Brough
This map shows the geographic impact of Rachel Brough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Brough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Brough more than expected).
Fields of papers citing papers by Rachel Brough
This network shows the impact of papers produced by Rachel Brough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Brough. The network helps show where Rachel Brough may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel Brough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Resistance to therapy caused by intragenic deletion in BRCA2 Hit paper breakdown → | 2008 | 758 |
| 2 | 2009 | 492 | |
| 3 | 2013 | 283 | |
| 4 | 2016 | 274 | |
| 5 | 2008 | 255 | |
| 6 | 2013 | 142 | |
| 7 | 2018 | 105 | |
| 8 | 2012 | 102 | |
| 9 | 2011 | 83 | |
| 10 | 2018 | 79 | |
| 11 | 2012 | 64 | |
| 12 | 2017 | 60 | |
| 13 | 2012 | 58 | |
| 14 | 2016 | 58 | |
| 15 | 2012 | 56 | |
| 16 | 2017 | 48 | |
| 17 | 2015 | 48 | |
| 18 | 2010 | 33 | |
| 19 | 2007 | 24 | |
| 20 | 2013 | 22 |
About Rachel Brough
Rachel Brough is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 39 papers that have together received 3.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (15 papers), PARP inhibition in cancer therapy (14 papers), CRISPR and Genetic Engineering (13 papers), Cancer-related Molecular Pathways (6 papers), BRCA gene mutations in cancer (5 papers), Chromatin Remodeling and Cancer (4 papers), Advanced Breast Cancer Therapies (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Oncology (2.0k citations), Molecular Biology (2.2k citations), Cancer Research (389 citations), Reproductive Medicine (217 citations) and Genetics (415 citations). Rachel Brough has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Christopher J. Lord, Alan Ashworth, Rachael Natrajan, Jorge S. Reis‐Filho, Radost Vatcheva, Stacey L. Edwards, Douglas A. Levine, Jeff Boyd, Jessica Frankum and Ilirjana Bajrami. Their work appears in journals such as Oncogene, Cancer Research, Cell Reports, PLoS ONE and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.